Alexandra Balcom
Patrimonio netto: - $ in data 31/07/2026
Patrimonio netto: - $ in data 31/07/2026
Alexandra Balcom is currently an Independent Director at Crescent Biopharma, Inc. since 2024.
Former roles include Director at Crescent Biopharma, Inc. (Old), Controller at Agios Pharmaceuticals, Inc., Vice President-Finance at SQZ Biotechnologies Co. from 2017 to 2021, and Chief Financial Officer & Treasurer at Nuvalent, Inc. from 2021 to 2026.
Education includes an MBA from Boston College and an undergraduate degree from the University of Massachusetts.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
-.--% | 02/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|
| Società | Posizione | Fine |
|---|---|---|
| NUVALENT, INC. | Direttore Finanziario/CFO | 15/07/2026 |
| SQZ BIOTECHNOLOGIES COMPANY | Corporate Officer/Principal | 01/03/2021 |
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
SQZ Biotechnologies Co.
SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale